1. Home
  2. Animal Drug Index - C
  3. Chlortetracycline

Animal NDC 66104-4396-9 Chlortetracycline

Animal Product Information

Field Name Field Value
Animal NDC Code 66104-4396-9
Proprietary Name Chlortetracycline What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Chlortetracycline What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Phibro Animal Health
Product Type Bulk Ingredient - Animal Drug
Active Ingredient(s)
  • Chlortetracycline
Marketing Category BULK INGREDIENT What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Chlortetracycline Images

Chlortetracycline Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Chlortetracycline - Aureomycin®B



CAS No. 

57-62-5

Health_1_Fire_1_

Reactivity_0_Special_-_

Emergency phone no. 24 hours:

Chemtrec 1-800-424-9300

FOR MANUFACTURING, PROCESSING OR REPACKING

MANUFACTURED BY:

PHIBRO ANIMAL HEALTH CORPORATION

One Duggar Drive

Willow Island, WV  36134-9711

USA

304-665-4100


Chlortetracycline Label



Label 


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.